Empaveli 1080 mg/20 mL (54 mg/mL) injection Images
Generic Name: pegcetacoplan
This medication has been identified as Empaveli 1080 mg/20 mL (54 mg/mL) injection. It is supplied by Apellis Pharmaceuticals, Inc.
Empaveli is used in the treatment of Paroxysmal Nocturnal Hemoglobinuria and belongs to the drug class selective immunosuppressants. Empaveli 1080 mg/20 mL (54 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Empaveli
- Generic Name
- pegcetacoplan
- Strength
- 1080 mg/20 mL (54 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apellis Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 73606-0010
See also:
Fabhalta
Fabhalta is used to treat paroxysmal nocturnal hemoglobinuria (PNH), primary immunoglobulin A ...
Soliris
Soliris infusion is used to treat paroxysmal nocturnal hemoglobinuria (PNH) or neuromyelitis optica ...
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Voydeya
Voydeya (danicopan) is an oral complement factor D inhibitor that may be used to treat ...
Bkemv
Bkemv (eculizumab-aeeb) is an interchangeable biosimilar to Soliris which may be used to treat ...
Epysqli
Epysqli (eculizumab-aagh), a biosimilar to Soliris, targets the complement system to treat ...
More about Empaveli (pegcetacoplan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.